FTO, FTO alpha-ketoglutarate dependent dioxygenase, 79068
N. diseases: 64; N. variants: 61
Source: GWASCAT ×
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phenotype | Laboratory Procedure | 324 | 837 | 0.100 | None | 1.000 | 4 | 4 | 2012 | 2018 | |||||
|
phenotype | Behavior and Behavior Mechanisms | Finding | 265 | 548 | 0.100 | None | 1.000 | 4 | 4 | 2010 | 2019 | ||||
|
phenotype | Clinical Attribute | 68 | 116 | 0.100 | None | 1.000 | 3 | 4 | 2015 | 2019 | |||||
|
phenotype | Clinical Attribute | 143 | 208 | 0.100 | None | 1.000 | 3 | 4 | 2017 | 2019 | |||||
|
disease | Musculoskeletal Diseases | Anatomical Abnormality | 578 | 1158 | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | ||||
|
phenotype | Finding | 136 | 326 | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||
|
disease | Finding | 578 | 1158 | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||
|
phenotype | Laboratory Procedure | 160 | 355 | 0.100 | None | 1.000 | 2 | 5 | 2017 | 2018 | |||||
|
phenotype | Laboratory or Test Result | 593 | 988 | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | |||||
|
phenotype | Laboratory Procedure | 593 | 988 | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||
|
phenotype | Laboratory Procedure | 90 | 174 | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||
|
phenotype | Laboratory Procedure | 100 | 250 | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | |||||
|
phenotype | Finding | 101 | 200 | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||
|
phenotype | Finding | 42 | 69 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
disease | Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | Disease or Syndrome | 46 | 72 | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Finding | 22 | 31 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
phenotype | Finding | 633 | 1159 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 5 | 9 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Finding | 122 | 190 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 308 | 766 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
disease | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Disease or Syndrome | 12 | 17 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||
|
disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 159 | 362 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||
|
phenotype | Laboratory Procedure | 138 | 216 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
disease | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Disease or Syndrome | 107 | 236 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |